Department of Genetic and Metabolic Diseases, Hadassah-Hebrew University Medical Center, 9112001, Jerusalem, Israel.
Medical Genetics Institute, Shaare Zedek Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Eur J Hum Genet. 2019 Aug;27(8):1315-1319. doi: 10.1038/s41431-019-0380-y. Epub 2019 Apr 11.
The transforming growth factor-beta (TGFβ) signaling pathway is essential for palatogenesis and retinal development. Glycoprotein A repetitions predominant (GARP), encoded by LRRC32, is a TGFβ cell surface receptor that has been studied primarily in the context of cellular immunity. We identified a homozygous stop-gain variant in LRRC32 (c.1630C>T; p.(Arg544Ter)) in two families with developmental delay, cleft palate, and proliferative retinopathy. Garp-null mice have palate defects and die within 24 h after birth. Our study establishes LRRC32 as a candidate disease-associated gene in humans and lends further support to the role of the TGFβ pathway in palatogenesis and retinal development.
转化生长因子-β(TGFβ)信号通路对于腭发生和视网膜发育至关重要。LRRC32 编码的糖蛋白 A 重复为主(GARP)是 TGFβ 细胞表面受体,主要在细胞免疫的背景下进行研究。我们在两个具有发育迟缓、腭裂和增殖性视网膜病变的家族中发现了 LRRC32 中的纯合终止变异(c.1630C>T;p.(Arg544Ter))。Garp 基因敲除小鼠有腭裂缺陷,并在出生后 24 小时内死亡。我们的研究将 LRRC32 确立为人类疾病相关基因的候选基因,并进一步支持 TGFβ 途径在腭发生和视网膜发育中的作用。